Back
Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
41
PSTV
Plus Therapeutics
Last Price:
1.15
Seasonality Move:
2.43%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.47
Seasonality Move:
27.93%
Sell
41
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $1.17. The Score for PSTV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.48. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
PSTV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 38.61 | Sell |
Chaikin Money Flow: | -26085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.34) | Sell |
Bollinger Bands (100): | (1.25 - 1.57) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.57 | Sell |
Relative Strength Index (14 RSI): | 22.44 | Sell |
Chaikin Money Flow: | -265638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.81 - 7.75) | Sell |
Bollinger Bands (100): | (7.43 - 15.15) | Sell |
PSTV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Sell |
20-day SMA: | 1.28 | Sell |
50-day SMA: | 1.32 | Sell |
200-day SMA: | 1.65 | Sell |
8-day EMA: | 1.28 | Sell |
20-day EMA: | 1.29 | Sell |
50-day EMA: | 1.33 | Sell |
200-day EMA: | 1.67 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.6 | Sell |
20-day SMA: | 4.18 | Sell |
50-day SMA: | 8.81 | Sell |
200-day SMA: | 12.34 | Sell |
8-day EMA: | 3.65 | Sell |
20-day EMA: | 4.83 | Sell |
50-day EMA: | 7.67 | Sell |
200-day EMA: | 10.3 | Sell |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Plus Therapeutics Technical Analysis
Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |